Sangamo BioSciences Enterprise Value:
356.08M for May 21, 2013Sangamo BioSciences Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 21, 2013 | 356.08M |
| May 20, 2013 | 355.81M |
| May 17, 2013 | 386.22M |
| May 16, 2013 | 377.15M |
| May 15, 2013 | 391.02M |
| May 14, 2013 | 410.23M |
| May 13, 2013 | 415.57M |
| May 10, 2013 | 403.83M |
| May 9, 2013 | 388.89M |
| May 8, 2013 | 356.34M |
| May 7, 2013 | 361.15M |
| May 6, 2013 | 378.75M |
| May 3, 2013 | 395.83M |
| May 2, 2013 | 448.65M |
| May 1, 2013 | 440.64M |
| April 30, 2013 | 479.59M |
| April 29, 2013 | 490.26M |
| April 26, 2013 | 496.66M |
| April 25, 2013 | 504.67M |
| April 24, 2013 | 471.59M |
| April 23, 2013 | 492.40M |
| April 22, 2013 | 483.86M |
| April 19, 2013 | 466.25M |
| April 18, 2013 | 444.38M |
| April 17, 2013 | 475.32M |
| April 16, 2013 | 452.91M |
| April 15, 2013 | 459.32M |
| April 12, 2013 | 480.66M |
| April 11, 2013 | 499.33M |
| April 10, 2013 | 476.39M |
| April 9, 2013 | 461.45M |
| April 8, 2013 | 445.98M |
| April 5, 2013 | 441.18M |
| April 4, 2013 | 429.44M |
| April 3, 2013 | 437.98M |
| April 2, 2013 | 437.98M |
| April 1, 2013 | 429.97M |
| March 28, 2013 | 446.51M |
| March 27, 2013 | 431.04M |
| March 26, 2013 | 426.77M |
| March 25, 2013 | 433.71M |
| March 22, 2013 | 433.71M |
| March 21, 2013 | 432.11M |
| March 20, 2013 | 435.84M |
| March 19, 2013 | 418.77M |
| March 18, 2013 | 428.37M |
| March 15, 2013 | 425.17M |
| March 14, 2013 | 433.17M |
| March 13, 2013 | 423.04M |
| March 12, 2013 | 433.17M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
SGMO Enterprise Value Benchmarks
| Companies | |
|---|---|
| Exact Sciences Corporation | 586.21M |
| Isis Pharmaceuticals | 1.937B |
| Achillion Pharmaceuticals | 584.62M |
SGMO Enterprise Value Rankings
| Overall |
65th percentile 2784 of 8002 |
| Sector |
62nd percentile 255 of 684 in Healthcare |
| Industry |
75th percentile 62 of 248 in Biotechnology |
SGMO Enterprise Value Range, Past 5 Years
| Minimum | 20.67M | Nov 12 2008 |
| Maximum | 512.67M | Mar 4 2013 |
| Average | 205.01M |
